Eggert, Martin <br/><br/>
An evaluation of anti-TNF-alpha-therapy in patients with ankylosing spondylitis: imbalanced activation of NF kappa B subunits in lymphocytes and modulation of serum cortisol concentration.  [electronic resource] 

 -  Rheumatology international  Jul 2007 
 - 841-6 p.  digital 
<br/><br/> Publication Type: Clinical Trial; Journal Article 
<br/><br/><label>ISSN: </label>0172-8172 
<br/><br/><label>Standard No.: </label>10.1007/s00296-007-0303-z  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adult<br/>Aged<br/>Antibodies, Monoclonal--administration & dosage<br/>Antirheumatic Agents--administration & dosage<br/>Biomarkers--analysis<br/>C-Reactive Protein--drug effects<br/>DNA-Binding Proteins--drug effects<br/>Female<br/>Humans<br/>Hydrocortisone--blood<br/>Infliximab<br/>Interleukin-6--blood<br/>Lymphocytes--drug effects<br/>Male<br/>Middle Aged<br/>NF-kappa B--drug effects<br/>NF-kappa B p50 Subunit--drug effects<br/>Spondylitis, Ankylosing--blood<br/>Transcription Factor RelA--drug effects<br/>Transcriptional Activation--drug effects<br/>Tumor Necrosis Factor-alpha--antagonists & inhibitors